August 6, 2009 (San Francisco, California) — A highly anticipated phase 3 randomized trial of early-stage nonsmall-cell lung cancer (NSCLC) patients failed to find a survival benefit with preoperative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results